RATIONALE: Temporal differentiation of operant behaviour is sensitive to dopaminergic manipulations. Previous studies using the fixed-interval peak procedure implicated D(2)-like dopamine receptors in these effects. However, recent findings suggest that d-amphetamine alters timing performance on the free-operant psychophysical procedure via D(1)-like receptors. It is not known whether this effect of d-amphetamine is mimicked by direct D(1)-like receptor stimulation. OBJECTIVE: The effects of a D(1)-like receptor agonist 6-chloro-2,3,4,5-tetrahydro-1-phenyl-1H-3-benzazepine (SKF-81297) on performance on the free-operant psychophysical procedure and the interaction between SKF-81297 and a D(1)-like receptor antagonist 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol (SKF-83566) and a D(2)-like receptor antagonist haloperidol, were examined. MATERIALS AND METHODS: Rats were trained to respond on two levers (A and B) under a free-operant psychophysical schedule, in which sucrose reinforcement was provided intermittently for responding on A during the first half and on B during the second half of 50-s trials. Logistic psychometric functions were fitted to the relative response rate data (percent responding on B [%B] vs time from trial onset [t]) under each treatment condition, and quantitative indices of timing (T(50) [value of t corresponding to %B = 50] and the Weber fraction [(T(75)-T(25))/2T(50); T(25) and T(75) are values of t corresponding to %B = 25 and %B = 75] were compared among treatments. RESULTS: SKF-81297 (0.8 mg kg(-1)) reduced T(50); this effect was antagonized by SKF-83566 (0.03 mg kg(-1)) but not by haloperidol (0.05, 0.1 mg kg(-1)). CONCLUSIONS: Stimulation of D(1)-like dopamine receptors affects performance in the free-operant psychophysical procedure.
RATIONALE: Temporal differentiation of operant behaviour is sensitive to dopaminergic manipulations. Previous studies using the fixed-interval peak procedure implicated D(2)-like dopamine receptors in these effects. However, recent findings suggest that d-amphetamine alters timing performance on the free-operant psychophysical procedure via D(1)-like receptors. It is not known whether this effect of d-amphetamine is mimicked by direct D(1)-like receptor stimulation. OBJECTIVE: The effects of a D(1)-like receptor agonist 6-chloro-2,3,4,5-tetrahydro-1-phenyl-1H-3-benzazepine (SKF-81297) on performance on the free-operant psychophysical procedure and the interaction between SKF-81297 and a D(1)-like receptor antagonist 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol (SKF-83566) and a D(2)-like receptor antagonist haloperidol, were examined. MATERIALS AND METHODS:Rats were trained to respond on two levers (A and B) under a free-operant psychophysical schedule, in which sucrose reinforcement was provided intermittently for responding on A during the first half and on B during the second half of 50-s trials. Logistic psychometric functions were fitted to the relative response rate data (percent responding on B [%B] vs time from trial onset [t]) under each treatment condition, and quantitative indices of timing (T(50) [value of t corresponding to %B = 50] and the Weber fraction [(T(75)-T(25))/2T(50); T(25) and T(75) are values of t corresponding to %B = 25 and %B = 75] were compared among treatments. RESULTS:SKF-81297 (0.8 mg kg(-1)) reduced T(50); this effect was antagonized by SKF-83566 (0.03 mg kg(-1)) but not by haloperidol (0.05, 0.1 mg kg(-1)). CONCLUSIONS: Stimulation of D(1)-like dopamine receptors affects performance in the free-operant psychophysical procedure.
Authors: S S al-Zahrani; M Y Ho; D N Velazquez Martinez; M Lopez Cabrera; C M Bradshaw; E Szabadi Journal: Psychopharmacology (Berl) Date: 1996-10 Impact factor: 4.530
Authors: T H C Cheung; G Bezzina; K Asgari; S Body; K C F Fone; C M Bradshaw; E Szabadi Journal: Psychopharmacology (Berl) Date: 2006-03-15 Impact factor: 4.530
Authors: Nandakumar S Narayanan; Benjamin B Land; John E Solder; Karl Deisseroth; Ralph J DiLeone Journal: Proc Natl Acad Sci U S A Date: 2012-11-26 Impact factor: 11.205
Authors: C M Olarte-Sánchez; L Valencia-Torres; H J Cassaday; C M Bradshaw; E Szabadi Journal: Psychopharmacology (Berl) Date: 2013-07-05 Impact factor: 4.530
Authors: S Body; T H C Cheung; C L Hampson; F S den Boon; G Bezzina; K C F Fone; C M Bradshaw; E Szabadi Journal: Psychopharmacology (Berl) Date: 2008-11-19 Impact factor: 4.530
Authors: Yusuf S Althobaiti; Farooq M Almutairi; Fahad S Alshehri; Ebtehal Altowairqi; Aliyah M Marghalani; Amal A Alghorabi; Walaa F Alsanie; Ahmed Gaber; Hashem O Alsaab; Atiah H Almalki; Alqassem Y Hakami; Turki Alkhalifa; Ahmad D Almalki; Ana M G Hardy; Zahoor A Shah Journal: Sci Rep Date: 2021-05-19 Impact factor: 4.379
Authors: L Valencia-Torres; C M Olarte-Sánchez; S Body; T H C Cheung; K C F Fone; C M Bradshaw; E Szabadi Journal: Behav Brain Res Date: 2012-08-16 Impact factor: 3.332